Insights

Cost-Effective Biotech Arable focuses on reducing costs of biomedical technology, products, services, and R&D, presenting an opportunity to position cost-saving value to potential partners, contract manufacturers, and CROs seeking more affordable cancer detection and treatment support tools.

Quantitative Cancer Detections The nano cytology platform promises rapid, quantitative cancer detection and staging. This offers sales angles to oncology clinics, hospital systems, and biotech developers aiming to accelerate clinical decision making and improve screening workflows.

Phototherapy Solutions AraLight LED phototherapy for rapid immune support and treatment adjuncts can be bundled with existing cancer care, recovery, or inflammatory disease programs, creating cross-sell opportunities with oncology centers, rehabilitation facilities, and integrative medicine providers.

Early Detection & Monitoring An emphasis on early detection and monitoring enables outreach to pharma and biotech companies seeking companion diagnostics, trial endpoints, and cost-efficient patient stratification tools to de-risk development pipelines.

Strategic Partnerships With a small team and growing tech stack, Arable could attract channel partners in contract research, clinical supply, and health-tech integrators to scale deployment, distribution, and commercialization of its quantitative platforms.

Similar companies to Arable

Arable Tech Stack

Arable uses 8 technology products and services including Snowplow, Google PageSpeed, Font Awesome, and more. Explore Arable's tech stack below.

  • Analytics
  • Google PageSpeed
    Caching
  • Font Awesome
    Font Scripts
  • Lightbox
    Javascript Libraries
  • Slick
    Javascript Libraries
  • Google Maps
    Maps
  • Bootstrap
    UI Frameworks
  • Apache HTTP Server
    Web Servers

Media & News

Arable's Email Address Formats

Arable uses at least 2 email formats:
Arable Email FormatsExamplePercentage
FLast@arablecorp.comJDoe@arablecorp.com
50%
First@arablecorp.comJohn@arablecorp.com
50%

Frequently Asked Questions

What is Arable's stock symbol?

Minus sign iconPlus sign icon
Arable is a publicly traded company; the company's stock symbol is WLDS.

What is Arable's official website and social media links?

Minus sign iconPlus sign icon
Arable's official website is arablecorp.com and has social profiles on LinkedIn.

How much revenue does Arable generate?

Minus sign iconPlus sign icon
As of August 2026, Arable's annual revenue is estimated to be <$1M.

What is Arable's NAICS code?

Minus sign iconPlus sign icon
Arable's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Arable have currently?

Minus sign iconPlus sign icon
As of August 2026, Arable has approximately 5 employees across 2 continents, including North America and Asia. Key team members include Corporate Director, Arable Corporation, India: M. S. R. Explore Arable's employee directory with LeadIQ.

What industry does Arable belong to?

Minus sign iconPlus sign icon
Arable operates in the Pharmaceutical Manufacturing industry.

What technology does Arable use?

Minus sign iconPlus sign icon
Arable's tech stack includes Snowplow, Google PageSpeed, Font Awesome, Lightbox, Slick, Google Maps, Bootstrap and Apache HTTP Server.

What is Arable's email format?

Minus sign iconPlus sign icon
Arable's email format typically follows the pattern of FLast@arablecorp.com. Find more Arable email formats with LeadIQ.

When was Arable founded?

Minus sign iconPlus sign icon
Arable was founded in 2010.
Arable logo

Arable

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

Arable is a pharmaceutical manufacturing company based in Palo Alto, California. Its work centers on reducing the costs of biomedical technology, products, and R&D while enabling advances in personalized medicine through early detection, treatment, and understanding of disease, with a focus on preventing illness. The company describes a suite of technologies that includes a nanotechnology-based live cell analytical platform and LED-based phototherapy, aiming to provide rapid, quantitative cancer detection and supportive treatments to strengthen the immune system during illness, injury recovery, or cancer therapies. Target customers likely include healthcare providers and researchers seeking faster cancer diagnostics and therapies that minimize patient distress and support immune recovery, as well as those developing new drugs who require timely, cost-efficient development tools. Arable positions itself within the biomedical technology and pharmaceutical landscape as an innovator offering quantitative diagnostic capabilities and phototherapy options to improve patient outcomes and reduce treatment-related burden. The company’s location is given as 530 University Avenue, Palo Alto, and its stated mission emphasizes improving quality of life by advancing early detection, treatment, and prevention of disease, though the presented information does not specify its founding date.

Section iconCompany Overview

Stock Symbol
WLDS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2010
Employees
2-10

Section iconFunding & Financials

  • <$1M

    Arable's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.